{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:46:57Z","timestamp":1790293617932,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003633.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000}}],"reference-count":126,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003633.pub3","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T15:09:48Z","timestamp":1514905788000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Botulinum toxin type A therapy for cervical dystonia"],"prefix":"10.1002","author":[{"given":"Mafalda","family":"Castel\u00e3o","sequence":"first","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel E","family":"Marques","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo S","family":"Duarte","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe B","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[{"name":"CHDI Foundation; 155 Village Boulevard Suite 200 Princeton NJ USA 08540"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen P","family":"Moore","sequence":"additional","affiliation":[{"name":"The Walton Centre NHS Foundation Trust; Lower Lane Liverpool UK L9 7LJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"10.1002\/14651858.CD003633.pub3-BIB0001|cit1","first-page":"276 (P4.243)","article-title":"A randomized double-blind, placebo-controlled study of intramuscular Botox for the treatment of cervical dystonia (CD)","volume":"13 Suppl 2","author":"Brashear","year":"1998","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD003633.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNF.0b013e31826538c7","article-title":"Efficacy, tolerability, and immunogenicity of onabotulinumtoxinA in a randomized, double-blind, placebo-controlled trial for cervical dystonia","volume":"35","author":"Charles","year":"2012","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0003|cit3","unstructured":"Comella C Botox for cervical dystonia Toxins'99 (www.wemove.org) 1999 8"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0004|cit4","first-page":"30","article-title":"A randomized, multicenter, placebo-controlled study of original otox (botulinum toxin type A) purified neurotoxin complex for the treatment of cervical dystonia","volume":"15 Suppl 2","author":"Hauser","year":"2000","journal-title":"Movement Disorders"},{"issue":"1-2","key":"10.1002\/14651858.CD003633.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041.","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN\u00ae, botulinumneurotoxin type A, without accessory proteins) in patients with cervical dystonia","volume":"308","author":"Comella","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/j.rehab.2013.07.1019","article-title":"Incobotulinumtoxin A (Xeomin) injected with flexible intervals is a well-tolerated long-term treatment of cervical dystonia","volume":"56","author":"Coulonn","year":"2013","journal-title":"Annals of Physical and Rehabilitation Medicine"},{"issue":"10S1","key":"10.1002\/14651858.CD003633.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S215 (P131)","DOI":"10.1016\/j.pmrj.2011.08.165","article-title":"IncobotulinumtoxinA (Xeomin; botulinumneurotoxin type A, free from accessory proteins): flexibility of dosing and injection intervals in cervical dystonia","volume":"3","author":"Evidente","year":"2011","journal-title":"PM&R"},{"issue":"1-2","key":"10.1002\/14651858.CD003633.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jns.2014.08.004","article-title":"IncobotulinumtoxinA (Xeomin\u00ae) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated","volume":"346","author":"Evidente","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"issue":"Meeting Abstrac","key":"10.1002\/14651858.CD003633.pub3-BIB0009|cit9","first-page":"P01.219","article-title":"IncobotulinumtoxinA (Xeomin\u00ae) remains well tolerated across flexible inter-injection intervals of 6-20 weeks in the treatment of cervical dystonia","volume":"78","author":"Fernandez","year":"2012","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"109-51 (P1070)","DOI":"10.1016\/j.jns.2013.07.403","article-title":"Long-term treatment of blepharospasm and cervical dystonia: incobotulinum toxin A is well tolerated when injected at flexible intervals based on patient needs","volume":"333","author":"Fernandez","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5334\/tohm.124","article-title":"Efficacy and safety of incobotulinumtoxinA in subjects previously treated with botulinum toxin versus toxin-na\u00efve subjects with cervical dystonia","volume":"3","author":"Fernandez","year":"2013","journal-title":"Tremor and Other Hyperkinetic Movements"},{"issue":"9S","key":"10.1002\/14651858.CD003633.pub3-BIB0012|cit12","first-page":"S29 (P49)","article-title":"Efficacy and safety of NT 201 (botulinum neurotoxin free from complexing proteins) in cervical dystonia","volume":"2","author":"Grafe","year":"2010","journal-title":"PM&R"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0013|cit13","first-page":"S365 (P1105)","article-title":"IncobotulinumtoxinA (NT 201, Xeomin) administered at flexible intervals of 6-20 weeks in subjects with cervical dystonia","volume":"27 Suppl.1","author":"Singer","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0014|cit14","first-page":"S211 (P625)","article-title":"IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with cervical dystonia across dosing intervals in a repeated dose-study","volume":"26 Suppl.2","author":"Truong","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0015|cit15","first-page":"244","article-title":"Double-blind, placebo-controlled study of botulinum toxin injection for torticollis","volume":"38 Suppl 1","author":"Greene","year":"1988","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/WNL.40.8.1213","article-title":"Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis","volume":"40(8)","author":"Greene","year":"1990","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0019|cit17","unstructured":"Poewe W Dysport for Cervical Dystonia Toxins'99 (www.wemove.org) 1999 10"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0017|cit18","first-page":"7","article-title":"Dysport for cervical dystonia","volume":"15 Suppl 2","author":"Poewe","year":"2000","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.64.1.13","article-title":"What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group","volume":"64","author":"Poewe","year":"1998","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0020|cit20","doi-asserted-by":"crossref","unstructured":"Poewe W Burbaud P Castelnovo G Jost WH Ceballos-Baumann AO Banach M Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: a randomized-controlled trial Movement Disorders 2016 [Epub ahead of print]","DOI":"10.1002\/mds.26760"},{"issue":"10","key":"10.1002\/14651858.CD003633.pub3-BIB0021|cit21","first-page":"S190 (P41)","article-title":"Health-related quality of life improvements with dysport in cervical dystonia","volume":"3 Suppl.1","author":"Coleman","year":"2011","journal-title":"PM&R"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00702-012-0872-1","article-title":"AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies","volume":"120","author":"Hauser","year":"2013","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0023|cit23","first-page":"1","article-title":"Improvement of SF-36 scores in cervical dystonia patients - is there a treatment effect when evaluating subscales?","volume":"126","author":"Jen","year":"2014","journal-title":"Basal Ganglia"},{"issue":"7","key":"10.1002\/14651858.CD003633.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.20403","article-title":"Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study","volume":"20","author":"Truong","year":"2005","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0025|cit25","first-page":"S306 (P1007)","article-title":"The efficacy and safety of Dysport (botulinumtype A toxin) in cervical dystonia: results of the first US study","volume":"17 Suppl 5","author":"Truong","year":"2002","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1002\/14651858.CD003633.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"e005150","DOI":"10.1136\/bmjopen-2014-005150","article-title":"Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study","volume":"4","author":"Mordin","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1002\/14651858.CD003633.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.parkreldis.2010.03.002","article-title":"Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia","volume":"16","author":"Truong","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0028|cit28","unstructured":"Kanovsky P Ruzicka E Jech R Roth J Schnider P Auff E Standardized dose of 500 Mu of Dysport for cervical dystonia: results of a prospective, randomized, double-blind, placebo-controlled study Movement Disorders 2000 31"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0030|cit29","unstructured":"Poewe W Dysport for cervical cystonia Toxins'99 (www.wemove.org) 1999 10"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0029|cit30","unstructured":"Poewe W Brans J Kessler K Kanovsky P Odergren T Aramideh M Dysport for cervical dystonia Movement Disorders 2000 7"},{"issue":"12","key":"10.1002\/14651858.CD003633.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s004150170028","article-title":"Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study","volume":"248","author":"Wissel","year":"2001","journal-title":"Journal of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003633.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.53.8.640","article-title":"Botulinum toxin treatment in spasmodic torticollis","volume":"53","author":"Blackie","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Turjanski N Blackie J Purves A Hambleton P Lees AJ Botulinus toxin in the treatment of spasmodic torticollis long-term results Journal of Neurology 2nd Congress of European Neurological Society 1990","DOI":"10.1136\/jnnp.53.8.640"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00002826-199404000-00008","article-title":"Determining a dose- effect curve for botulinum toxin in the sternocleidomastoid muscle in cervical dystonia","volume":"17","author":"Buchman","year":"1994","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0035|cit35","first-page":"320","article-title":"Change in pattern of muscle activity following botulinum toxin injections for torticollis","volume":"39 Suppl 1","author":"Gelb","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Gelb DJ Lowenstein DH Aminoff MJ Botulinum toxin in the treatment of spasmodic torticollis Neurology 1988 244","DOI":"10.1212\/WNL.39.1.80"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.39.1.80","article-title":"Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis","volume":"39","author":"Gelb","year":"1989","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003633.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002826-199008000-00011","article-title":"Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis","volume":"13","author":"Koller","year":"1990","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes","volume":"14","author":"Lange","year":"1991","journal-title":"Muscle and Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/mds.870060210","article-title":"Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double-blind study on twenty-three patients","volume":"6","author":"Lorentz","year":"1991","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003633.pub3-BIB0041|cit41","first-page":"189","article-title":"Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia","volume":"94","author":"Lu","year":"1995","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0042|cit42","first-page":"73 (P262)","article-title":"Botulinum toxin therapy for blepharospasm, hemifacial spasm and spasmodic torticollis: clinical studies with a follow-up of 40 months","volume":"5 Suppl 1","author":"Maurri","year":"1990","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.54.9.813","article-title":"A double blind trial of botulinum toxin \"A\" in torticollis, with one year follow up","volume":"54(9)","author":"Moore","year":"1991","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003633.pub3-BIB0044|cit44","first-page":"813","article-title":"Double blind study of botulinum toxin A in torticollis","volume":"54","author":"Moore","year":"1991","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0168-5597(94)90150-3","article-title":"Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study","volume":"93(6)","author":"Ostergaard","year":"1994","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0046|cit46","first-page":"352","article-title":"Double-blind, placebo-controlled, crossover trial of botulinum-A toxin for torticollis","volume":"39 Suppl 1","author":"Perlmutter","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0047|cit47","first-page":"S185 (6-17-01)","article-title":"Botulinum toxin type A injections for cervical dystonia: a double-blind, placebo controlled study","volume":"20 Suppl 4","author":"Relja","year":"1993","journal-title":"The Canadian Journal of Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0048|cit48","first-page":"245","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0049|cit49","first-page":"593","article-title":"Botulinum toxin in spasmodic torticollis","volume-title":"Advances in Neurology","volume":"50: Dystonia 2","author":"Tsui","year":"1988"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0050|cit50","first-page":"75 (P268)","article-title":"Long term follow-up of patients treated with botulinum toxin for spasmodic torticollis","volume":"5 (Suppl 1)","author":"Yoshimura","year":"1990","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/sim.2423","article-title":"Meta-analysis of heterogeneously reported trials assessing change from baseline","volume":"24","author":"Abrams","year":"2005","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","article-title":"EFNS guidelines on diagnosis and treatment of primary dystonias","volume":"18","author":"Albanese","year":"2011","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003633.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2288-2-3","article-title":"Meta-analysis, Simpson's paradox, and the number needed to treat","volume":"2","author":"Altman","year":"2002","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"3689-96","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin","volume":"28","author":"Antonucci","year":"2008","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD003633.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/ene.12650","article-title":"Isolated and combined dystonia syndromes - an update on new genes and their phenotypes","volume":"22","author":"Balint","year":"2015","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003633.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0058|cit58","first-page":"495-504","article-title":"On the question of permeability of the blood-brain barrier to botulinum toxin","volume":"48","author":"Boroff","year":"1975","journal-title":"International Archives of Allergy and Applied Immunology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1477-7525-4-69","article-title":"How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure","volume":"4","author":"Bro\u017cek","year":"2006","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0060|cit60","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942283","volume-title":"Multiple Imputation and its Application","author":"Carpenter","year":"2013"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/mds.870060206","article-title":"Idiopathic cervical dystonia: clinical characteristics","volume":"6","author":"Chan","year":"1991","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0062|cit62","volume-title":"Statistical Power Analysis in the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mdc3.12131","article-title":"Development of the comprehensive cervical dystonia rating scale: methodology","volume":"2","author":"Comella","year":"2015","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jrsm.1090","article-title":"Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool","volume":"5","author":"Corbett","year":"2014","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0065|cit65","first-page":"3200-5","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"Paiva","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0066|cit66","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"tre","DOI":"10.5334\/tohm.170","article-title":"Descriptive epidemiology of cervical dystonia","volume":"3","author":"Defazio","year":"2013","journal-title":"Tremor and Other Hyperkinetic Movements"},{"issue":"10","key":"10.1002\/14651858.CD003633.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004314.pub3","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","author":"Duarte","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(71)90129-8","article-title":"An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse","volume":"14","author":"Duchen","year":"1971","journal-title":"Journal of the Neurological Sciences"},{"issue":"9237","key":"10.1002\/14651858.CD003633.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s004150070094","article-title":"A prevalence study of primary dystonia in eight European countries","volume":"247","author":"Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"400-4","DOI":"10.3109\/00016489309135834","article-title":"Botulinum A toxin effects on rat jaw muscle spindles","volume":"113","author":"Filippi","year":"1993","journal-title":"Acta Oto-laryngologica"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follmann","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3171\/jns.1959.16.1.0055","article-title":"Experimental spasmodic torticollis","volume":"16","author":"Foltz","year":"1959","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0075|cit75","first-page":"325","article-title":"Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?","volume":"4","author":"Frevert","year":"2010","journal-title":"Biologics: Targets & Therapy"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0077|cit77","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"12","key":"10.1002\/14651858.CD003633.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence-imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD003633.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneur.55.5.601","article-title":"The neurophysiology of dystonia","volume":"55","author":"Hallett","year":"1998","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0080|cit80","volume-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"issue":"7414","key":"10.1002\/14651858.CD003633.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0082|cit82","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0083|cit83","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0084|cit84","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1167-79","DOI":"10.1016\/0306-4522(81)90081-6","article-title":"Nerve growth in botulinum toxin poisoned muscles","volume":"6","author":"Holland","year":"1981","journal-title":"Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD003633.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","article-title":"False-positive findings in Cochrane meta-analyses with and without application of Trial Sequential Analysis: an empirical review","volume":"6","author":"Imberger","year":"2016","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.1990.00530050070014","article-title":"Natural history of adult-onset idiopathic torticollis","volume":"47","author":"Jahnanshani","year":"1990","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"951-7","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003633.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"411-6","DOI":"10.1016\/j.parkreldis.2007.02.005","article-title":"Prevalence of cervical dystonia and spasmodic torticollis in the United States general population","volume":"13","author":"Jankovic","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1002\/14651858.CD003633.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0960-8966(96)00041-7","article-title":"Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle","volume":"6","author":"Juzans","year":"1996","journal-title":"Neuromuscular Disorders : NMD"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1745-6215-15-49","article-title":"Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs)","volume":"15","author":"Macefield","year":"2014","journal-title":"Trials"},{"issue":"5","key":"10.1002\/14651858.CD003633.pub3-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004315.pub3","article-title":"Botulinum toxin type B for cervical dystonia","author":"Marques","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"39-59","DOI":"10.1016\/j.pneurobio.2014.06.001","article-title":"Botulinum toxin A, brain and pain","volume":"119-120","author":"Matak","year":"2014","journal-title":"Progress in Neurobiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"issue":"23","key":"10.1002\/14651858.CD003633.pub3-BIB0099|cit99","first-page":"54-60","article-title":"Neurophysiological changes after intramuscular injection of botulinum toxin","volume":"123","author":"Palomar","year":"2012","journal-title":"Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"259-68","DOI":"10.1098\/rstb.1999.0377","article-title":"Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses","volume":"354","author":"Pellizzari","year":"1999","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD003633.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0102|cit102","unstructured":"Nordic Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"488-96","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"71-80","DOI":"10.1111\/j.1468-1331.2010.03056.x","article-title":"On muscle spindles, dystonia and botulinum toxin","volume":"17","author":"Rosales","year":"2010","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"585-98","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0106|cit106","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"10","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"7197","key":"10.1002\/14651858.CD003633.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analysis - sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0110|cit110","unstructured":"StataCorp Stata Statistical Software: release 14 2015"},{"issue":"14","key":"10.1002\/14651858.CD003633.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.25244","article-title":"The prevalence of primary dystonia: a systematic review and meta-analysis","volume":"27","author":"Steeves","year":"2012","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1002\/14651858.CD003633.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0113|cit113","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/mds.870120117","article-title":"Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin","volume":"12","author":"Tarsy","year":"1997","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMra055549","article-title":"Dystonia","volume":"355","author":"Tarsy","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0116|cit116","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa \u0307manual.pdf 2011"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0117|cit117","unstructured":"Copenhagen Trial Unit Trial Sequential Analysis. Version 0.9 Beta 2011"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","article-title":"OMERACT: an international initiative to improve outcome measurement in rheumatology","volume":"8","author":"Tugwell","year":"2007","journal-title":"Trials"},{"issue":"2","key":"10.1002\/14651858.CD003633.pub3-BIB0119|cit119","first-page":"31","article-title":"Comparison and overview of currently available neurotoxins","volume":"7","author":"Walker","year":"2014","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial Sequential Analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD003633.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","article-title":"A systematic review identifies a lack of standardization in methods for handling missing variance data","volume":"59","author":"Wiebe","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD003633.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s00415-012-6510-x","article-title":"Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value","volume":"259","author":"Zoons","year":"2012","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0124|cit124","first-page":"29","article-title":"Botulinum toxin type A for the treatment of cervical dystonia: a systematic review","volume":"15 Suppl 3","author":"Costa","year":"2000","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003633.pub3-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003633.pub2","article-title":"Botulinum toxin type A therapy for cervical dystonia","author":"Costa","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003633.pub3-BIB0126|cit126","first-page":"76","article-title":"Botulinum toxin type A for the treatment of cervical dystonia: a systematic review","volume":"6 Suppl 3","author":"Ferreira","year":"1999","journal-title":"European Journal of Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003633.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003633.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T03:06:15Z","timestamp":1719716775000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003633.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":126,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003633.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}